Related content

Comparison of the effects of raloxifene and low-dose hormone replacement therapy on bone mineral density and bone turnover in the treatment of postmenopausal osteoporosis

By Dane Cem   Dane Banu   Cetin Ahmet   Erginbas Murat  

Gynecological Endocrinology, Vol. 23, Iss. 7, 2007-07 ,pp. : 398-403

Informa Healthcare

Access to resources Recommend Favorite

Puberty, ageing and hormone replacement therapy. The effect of a change in the dose of trimegestone on the pattern of bleeding in estrogen-treated post-menopausal women: 6 month extension of a dose-ranging study

By Wahab May  

Human Reproduction, Vol. 17, Iss. 5, 2002-05 ,pp. : 1386-1390

Oxford University Press

Access to resources Recommend Favorite

Acceptability and patterns of uterine bleeding in sequential trimegestone-based hormone replacement therapy: a dose-ranging study

By Al-Azzawi F  

Human Reproduction, Vol. 14, Iss. 3, 1999-03 ,pp. : 636-641

Oxford University Press

Access to resources Recommend Favorite

Long-term low-dose oral administration of dehydroepiandrosterone modulates adrenal response to adrenocorticotropic hormone in early and late postmenopausal women

By Genazzani Andrea R.   Pluchino Nicola   Begliuomini Silvia   Stomati Massimo   Bernardi Francesca   Pieri Matteo   Casarosa Elena   Palumbo Marco   Genazzani Alessandro D.   Luisi Michele  

Gynecological Endocrinology, Vol. 22, Iss. 11, 2006-11 ,pp. : 627-635

Informa Healthcare

Access to resources Recommend Favorite

Variations on hormone replacement therapy: An answer to the 'one dose fits all' Women's Health Initiative study

By Studd John  

Gynecological Endocrinology, Vol. 23, Iss. 11, 2007-11 ,pp. : 665-671

Informa Healthcare

Access to resources Recommend Favorite